Search

everythinglearnresearchcommunity

for

Search:↓

A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.

Female hair loss patients more likely to have dry eye and gland issues.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Testosterone therapy increases bone density in older men with low testosterone levels.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Lowering testosterone speeds up wound healing in male mice.

Minoxidil and finasteride effectively treat hair loss.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Reduced AR gene methylation may cause early pubic hair growth in girls.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.